Loading institutional data...
Loading institutional data...
Held by 381 of 5,944 reporting institutions (96th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $150.86 today, the market must believe free cash flow compounds 9.4%/yr for a decade (off $209M normalized FCF).
The market's 9.4% is more optimistic than its 9-yr track record.
2-stage DCF · 0.03B shares · net debt $100M
mean 9.9% · volatility σ 62% · implied rate exceeded in 4/9 yrs
Central path = implied 9.4%/yr growth; shaded band = ±1σ (62%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash conversion lags reported earnings — watch accruals. Lower/negative accruals = higher quality (Sloan).
Comfortably covers interest; leverage rising year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $859M buybacks = $859M returned on $94M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Reinvestment has been productive — operating income grew well per dollar put in. Current ROIC on all capital: 13%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $265M covers the $156M due within a year 1.7× over. Scheduled principal only (excludes interest & revolver draws). As of 2011-12-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Interest is easily covered by operating profit. Effective rate ~5.9% on $365M of debt.
Cash of $265M fully covers short-term debt of $0.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-09-14
Nothing notable to watch.
No material risks flagged.
Where each multiple sits in its own 14-yr range · 31th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 4.9× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 65.5 | 65.2 | 68.0 | 69.0 | 68.2 | 67.5 | 68.0 | 67.9 |
| Gross Profit | — | — | — | — | 31.8 | 32.5 | 32.0 | 32.1 |
| SG&A | 23.0 | 21.4 | 19.8 | 19.4 | 21.2 | 21.5 | 22.2 | 21.1 |
| Operating Income | 11.1 | 13.0 | 11.5 | 11.2 | 10.0 | 10.8 | 9.4 | 10.3 |
| Income Tax | 2.8 | 3.0 | 2.1 | 2.3 | 2.1 | 2.4 | 1.9 | 2.6 |
| Net Income | 7.4 | 9.2 | 8.6 | 8.5 | 7.8 | 7.9 | 7.6 | 7.1 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on FCN: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
EOD close · as of 2026-09-14
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.79B 100.0% | $3.70B 100.0% | $3.49B 100.0% | $3.03B 100.0% | $2.78B 100.0% | $2.46B 100.0% | $2.35B 100.0% | $2.03B 100.0% | $1.81B 100.0% | $1.81B 100.0% |
| Cost of Revenue | $2.57B 67.9% | $2.52B 68.0% | $2.35B 67.5% | $2.07B 68.2% | $1.92B 69.0% | $1.67B 68.0% | $1.53B 65.2% | $1.33B 65.5% | $1.22B 67.2% | $1.21B 66.9% |
| Gross Profit | $1.22B 32.1% | $1.18B 32.0% | $1.14B 32.5% | $962.9M 31.8% | — | — | — | — | — | — |
| Selling, General & Admin | $799.6M 21.1% | $822.2M 22.2% | $751.3M 21.5% | $641.1M 21.2% | $537.8M 19.4% | $488.4M 19.8% | $504.1M 21.4% | $465.6M 23.0% | $432.0M 23.9% | $436.7M 24.1% |
| Total Operating Expenses | $3.40B 89.7% | $3.35B 90.6% | $3.11B 89.2% | $2.73B 90.0% | $2.46B 88.8% | $2.18B 88.5% | $2.05B 87.0% | $1.80B 88.9% | $1.70B 94.0% | $1.67B 92.1% |
| Operating Income | $389.1M 10.3% | $347.4M 9.4% | $377.6M 10.8% | $303.9M 10.0% | $312.0M 11.2% | $282.7M 11.5% | $305.6M 13.0% | $226.0M 11.1% | $108.7M 6.0% | $142.2M 7.9% |
| Interest Expense | $21.4M 0.6% | $7.0M 0.2% | $14.3M 0.4% | $10.0M 0.3% | $20.3M 0.7% | $19.8M 0.8% | $19.2M 0.8% | $27.1M 1.3% | $25.4M 1.4% | $24.8M 1.4% |
| Other Income (Expense), net | -$18.1M -0.5% | $3.4M 0.1% | -$19.2M -0.6% | -$6.1M -0.2% | -$14.1M -0.5% | -$20.2M -0.8% | -$17.1M -0.7% | -$18.2M -0.9% | -$21.6M -1.2% | -$14.4M -0.8% |
| Pretax Income | $371.0M 9.8% | $350.8M 9.5% | $358.4M 10.3% | $297.7M 9.8% | $297.9M 10.7% | $262.4M 10.7% | $288.4M 12.3% | $207.8M 10.2% | $87.1M 4.8% | $127.8M 7.1% |
| Income Tax Expense | $100.1M 2.6% | $70.7M 1.9% | $83.5M 2.4% | $62.2M 2.1% | $63.0M 2.3% | $51.8M 2.1% | $71.7M 3.0% | $57.2M 2.8% | -$20.9M -1.2% | $42.3M 2.3% |
| Net Income | $270.9M 7.1% | $280.1M 7.6% | $274.9M 7.9% | $235.5M 7.8% | $235.0M 8.5% | $210.7M 8.6% | $216.7M 9.2% | $150.6M 7.4% | $108.0M 6.0% | $85.5M 4.7% |
| Per Share | ||||||||||
| EPS (Basic) | $8.33 | $7.96 | $8.10 | $6.99 | $7.02 | $5.92 | $5.89 | $4.06 | $2.79 | $2.09 |
| EPS (Diluted) | $8.24 | $7.81 | $7.71 | $6.58 | $6.65 | $5.67 | $5.69 | $3.93 | $2.75 | $2.05 |
| Weighted Avg Shares (Basic) | 32.5M | 35.2M | 33.9M | 33.7M | 33.5M | 35.6M | 36.8M | 37.1M | 38.7M | 40.9M |
| Weighted Avg Shares (Diluted) | 32.9M | 35.8M | 35.6M | 35.8M | 35.3M | 37.1M | 38.1M | 38.3M | 39.2M | 41.7M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Ranked against 651 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| LTM | $29.18T | — | — | — | — | — | — | — | — | — | 160 |
| CAT | $364.8B | 41.7× | 29.1× | 5.4× | 4.3% | 33.8% | 13.1% | 41.7% | 15.4% | 2.7× | 3,616 |
| GE | $333.0B | 39.0× | — | 7.3× | 18.5% | — | 19.0% | 46.6% | 22.2% | — | 3,077 |
| RTX | $262.2B | 39.4× | 18.6× | 3.0× | 9.7% | — | 7.6% | 10.3% | 10.3% | 0.0× | 3,277 |
| BA | $212.8B | 84.8× | 42.4× | 2.4× | 34.5% | 4.8% | 2.5% | 41.0% | 3.3% | 10.0× | 2,435 |
| DE | $184.3B | 36.8× | — | 4.0× | -11.7% | — | 11.0% | 19.4% | 12.6% | — | 2,491 |
| ABBNY | $170.8B | 46.1× | 30.5× | 5.3× | 9.5% | 34.8% | 11.9% | 28.5% | 20.4% | 0.9× | 48 |
| UNP | $169.1B | 23.8× | 16.2× | 6.9× | 1.1% | — | 29.1% | 38.7% | 14.2% | 2.6× | 2,648 |
| ETN | $152.5B | 37.6× | — | 5.6× | 10.3% | 37.6% | 14.9% | 21.0% | 13.9% | — | 2,398 |
| HON | $127.9B | 27.4× | 15.8× | 3.4× | 7.8% | 36.9% | 12.6% | 34.0% | 9.8% | 3.6× | 2,694 |
| LMT | $121.2B | 24.6× | 15.9× | 1.6× | 5.6% | 10.2% | 6.7% | 74.6% | 17.7% | 2.5× | 2,807 |
| PH | $119.2B | 34.3× | 26.9× | 6.0× | -0.4% | 36.9% | 17.8% | 25.8% | 16.7% | 1.6× | 1,845 |
| ADP | $110.0B | 25.3× | — | 5.0× | 6.7% | 46.4% | 20.1% | 73.2% | 40.1% | — | 2,179 |
| GD | $96.5B | 23.1× | 16.9× | 1.8× | 10.1% | — | 8.0% | 16.4% | 12.5% | 1.3× | 2,123 |
| TT | $95.0B | 32.8× | 23.4× | 4.5× | 7.5% | — | 13.7% | 34.0% | 22.1% | 1.1× | 1,658 |
| PWR | $93.0B | 91.5× | 46.1× | 3.3× | 20.3% | 15.0% | 3.6% | 11.5% | 10.6% | 0.4× | 1,659 |
| HWM | $91.2B | 61.2× | 40.2× | 11.1× | 11.1% | — | 18.3% | 28.2% | 17.9% | 1.3× | 1,399 |
| CSX | $91.0B | 31.8× | 14.7× | 6.5× | -3.1% | — | 20.5% | 22.0% | 22.0% | — | 1,791 |
| VRT | $90.8B | 69.6× | 43.0× | 8.9× | 27.7% | 36.3% | 13.0% | 33.8% | 19.4% | 1.4× | 1,748 |
| JCI | $89.8B | 27.4× | — | 3.8× | 2.8% | 36.4% | 13.9% | 25.5% | 14.4% | — | 1,487 |
| WM | $87.9B | 32.5× | 12.3× | 3.5× | 14.2% | 40.4% | 10.7% | 27.1% | 25.3% | 0.1× | 2,262 |
| UPS | $87.0B | 15.6× | 9.7× | 1.0× | -2.6% | — | 6.3% | 34.3% | 13.8% | 2.2× | 2,025 |
| MMM | $85.9B | 27.0× | 16.6× | 3.4× | 1.5% | 39.9% | 13.0% | 69.1% | 18.8% | 2.1× | 2,051 |
| EMR | $83.5B | 36.7× | — | 4.6× | 3.0% | 52.8% | 12.7% | 11.3% | 6.9% | — | 2,112 |
| CTAS | $80.9B | 45.6× | 29.1× | 7.8× | 7.7% | 50.0% | 17.5% | 38.7% | 25.5% | 0.8× | 1,366 |
| FCN | $4.7B | 18.3× | 10.9× | 1.2× | 2.4% | 32.1% | 7.1% | 15.6% | 12.9% | 0.8× | 381 |
Peers = companies sharing FCN's sector (Industrials) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.